about
Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children.A proteomic approach to obesity and type 2 diabetes.Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations.Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.The impact of intrauterine and extrauterine weight gain in premature infants on later body composition.Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literature.Underdiagnosed Beckwith-Wiedemann syndrome among early onset obese children.[Skeletal dysplasias: New medical treatments].Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children.[Hypophosphatasia: Clinical manifestations, diagnostic recommendations and therapeutic options].Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.Response to growth hormone in patients with mutationsMetabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatmentClinical management of childhood hyperthyroidism with and without Down syndrome: a longitudinal study at a single centerFrequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature reviewEfficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label StudySUN-529 Burden of Illness in Adults with Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry.Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population[X-linked hypophosphatemic rickets due to mutations in PHEX: Clinical and evolutionary variability]LZTR1: Genotype Expansion in Noonan Syndrome[Influence of neonatal anthropometry on the comorbidities of the obese patient][Parental obesity is associated with the severity of childhood obesity and its comorbidities][Implication in Paediatrics of the First International Consensus Statement for the Diagnosis and management of pseudohypoparathyroidism and related disorders]Wind of change in pseudohypoparathyroidism and related disorders: New classification and first international management consensus[The importance of socioeconomic factors in obesity studies. Authors reply]Sex, puberty, and ethnicity have a strong influence on growth and metabolic comorbidities in children and adolescents with obesity: Report on 1300 patients (the Madrid Cohort)Heterozygous rare genetic variants in non-syndromic early-onset obesityNatural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study
P50
Q33776670-6B467F08-DC04-4FD3-BB85-E79C54B0D9A1Q35879468-DA87E25E-1E22-47ED-887B-91EDFF21F953Q36759492-8A710C67-75B1-4AE5-8DAA-CA4B196324AEQ37324986-4191602E-BC1E-4FE0-804D-F30E71F02987Q43120001-2FA395D2-19A7-4193-84EF-42CEC5CCEA14Q47202269-F63B2CFC-A5C8-4A08-B5CA-B90BA6B044C2Q49720076-E6BF9EE6-FD18-417C-8F5C-4A3DB13AE656Q50463742-39641C73-299E-4022-B55D-97AB9B90D524Q50517587-CD5AFEF1-8192-459E-B2C2-46DE3238421EQ50956105-8B8585FC-CCF7-43AA-8A1F-772E269F1AF4Q53156468-9DFA1C4E-BC6A-4AEC-84EC-792DB39084DEQ53739961-4FE072F4-2557-4464-9C26-BDE5E3D475A5Q60175692-F0318E92-4F89-4576-97C8-97EB24F04B3DQ61647669-6DC4ED11-09EB-48B3-ABE1-037B1BC40D5FQ61647670-2DD96840-2A47-4070-B3D7-AFE4D779F4D3Q64089884-E58AAB43-10AE-463C-9013-3DE8575D2D41Q64277116-3E90E89B-AD67-475A-8F82-8DF99EA0C993Q64914615-A64499B3-7B21-4F60-9832-2921FEA19D82Q89079086-883E0D50-5AC3-4347-9A3F-4267CADACAF3Q89276472-94B5F832-E849-4AB7-9301-4E053B7F92D3Q90163152-5BBA6EB6-7CB0-419E-8E16-B0AE437DFBC0Q90450151-E5B9BA87-6ED9-4120-A1A4-FB47D3DA805AQ90578543-68D463D2-FF87-44DC-B81B-D2A672DC19B4Q90783866-7AA4314F-B608-4245-853D-4D09FDB19016Q91649455-CCCE184D-18EA-463D-9711-DD017795BE5FQ92089467-443C165D-9A3C-4A54-8C49-82E059339019Q92363755-0852D575-2E37-43D0-9296-6A26CF14DAFEQ92709159-52171A1D-4AFD-422B-B7CA-7B212D82384EQ93063587-B6943213-2B8F-44CA-AFBA-1F342166200A
P50
description
researcher
@en
name
G Á Martos-Moreno
@en
type
label
G Á Martos-Moreno
@en
prefLabel
G Á Martos-Moreno
@en
P31
P496
0000-0001-5524-2646